Physician profile
Argil Wheelock
NPI 1700811346
$47,004.19
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $418 · 2020: $151 · 2021: $245 · 2022: $884 · 2023: $23K · 2024: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $45K · Food and Beverage: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $45,143.00 |
| Food and Beverage | $163.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $45,377.54 | 2022-2024 | |
| Boston Scientific Corporation | $444.43 | 2019-2024 | |
| Rochester Medical Corporation | $221.08 | 2019-2022 | |
| Urogen Pharma, INC. | $166.81 | 2022 | |
| Medtronic, INC. | $131.06 | 2022 | |
| Axonics, INC. | $122.48 | 2020-2022 | |
| Covidien Lp | $118.41 | 2019 | |
| Neotract INC. | $113.08 | 2020 | |
| Coloplast Corp | $109.55 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $85.42 | 2019-2024 | Bard Urinary Drainage Bag |
| Cook Medical LLC | $49.58 | 2019 | |
| Travere Therapeutics, INC. | $19.26 | 2022 | |
| Janssen Biotech, INC. | $17.42 | 2022 | |
| Photocure INC | $14.52 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Argil Wheelock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.